|
ERCC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.786000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.209600E-02 |
| Normal-vs-Stage2 |
1.565550E-02 |
| Normal-vs-Stage3 |
9.66199999999917E-05 |
| Normal-vs-Stage4 |
6.81770000010573E-07 |
| Stage1-vs-Stage2 |
2.059800E-01 |
| Stage1-vs-Stage3 |
7.539700E-03 |
| Stage1-vs-Stage4 |
3.008400E-04 |
| Stage2-vs-Stage3 |
5.309800E-01 |
| Stage2-vs-Stage4 |
1.540770E-01 |
| Stage3-vs-Stage4 |
2.926000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.614400E-04 |
| Normal-vs-AfricanAmerican |
1.191890E-04 |
| Normal-vs-Asian |
8.590400E-01 |
| Caucasian-vs-AfricanAmerican |
1.037010E-01 |
| Caucasian-vs-Asian |
3.561600E-01 |
| AfricanAmerican-vs-Asian |
1.028440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.827350E-04 |
| Normal-vs-Female |
6.455300E-03 |
| Male-vs-Female |
3.363200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.242230E-03 |
| Normal-vs-Age(41-60Yrs) |
1.103650E-02 |
| Normal-vs-Age(61-80Yrs) |
3.797700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.456440E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.422620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.525600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.798800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.327810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.240650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.927000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.596000E-01 |
| Normal-vs-Grade 2 |
5.222000E-02 |
| Normal-vs-Grade 3 |
1.048040E-04 |
| Normal-vs-Grade 4 |
1.25629999958576E-07 |
| Grade 1-vs-Grade 2 |
5.869000E-01 |
| Grade 1-vs-Grade 3 |
1.067030E-01 |
| Grade 1-vs-Grade 4 |
8.116000E-03 |
| Grade 2-vs-Grade 3 |
1.662020E-02 |
| Grade 2-vs-Grade 4 |
4.39020000000401E-05 |
| Grade 3-vs-Grade 4 |
1.665640E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.639800E-01 |
| Normal-vs-ccB subtype |
3.582800E-04 |
| ccA subtype-vs-ccB subtype |
3.594200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.404900E-03 |
| Normal-vs-N1 |
5.864400E-03 |
| N0-vs-N1 |
2.147000E-01 |
|
|
